These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20129447)

  • 41. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial.
    De Simone P; Metselaar HJ; Fischer L; Dumortier J; Boudjema K; Hardwigsen J; Rostaing L; De Carlis L; Saliba F; Nevens F
    Liver Transpl; 2009 Oct; 15(10):1262-9. PubMed ID: 19790150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role and value of sirolimus administration in kidney and liver transplantation.
    Mehrabi A; Fonouni H; Kashfi A; Schmied BM; Morath Ch; Sadeghi M; Schemmer P; Encke J; Sauer P; Zeier M; Weitz J; Büchler MW; Schmidt J
    Clin Transplant; 2006; 20 Suppl 17():30-43. PubMed ID: 17100699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
    Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic ifosfamide nephrotoxicity in children.
    Skinner R
    Med Pediatr Oncol; 2003 Sep; 41(3):190-7. PubMed ID: 12868118
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease.
    Stephany BR; Boumitri M; Budev M; Alao B; Poggio ED
    J Heart Lung Transplant; 2009 Jun; 28(6):564-71. PubMed ID: 19481016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapamycin rescue therapy in patients after kidney transplantation: first clinical experience.
    Weber T; Abendroth D; Schelzig H
    Transpl Int; 2005 Feb; 18(2):151-6. PubMed ID: 15691266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. mTOR inhibitor/proliferation signal inhibitors: entering or leaving the field?
    Rostaing L; Kamar N
    J Nephrol; 2010; 23(2):133-42. PubMed ID: 20155724
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biomarkers of calcineurin inhibitor nephrotoxicity in transplantation.
    Fernando M; Peake PW; Endre ZH
    Biomark Med; 2014; 8(10):1247-62. PubMed ID: 25525985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The over-exaggerated chronic nephrotoxicity of calcineurin inhibitors.
    Issa N; Kukla A; Ibrahim HN
    Arab J Urol; 2012 Jun; 10(2):169-74. PubMed ID: 26558021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD44 as a pathological marker for the early detection of calcineurin inhibitor-induced nephrotoxicity post kidney transplantation.
    Hayashi A; Okamoto T; Nio-Kobayashi J; Iwahara N; Suzuki R; Ueda Y; Takahashi T; Yasuyuki Sato ; Iwanaga T; Hotta K
    Biomed Res; 2022; 43(5):181-186. PubMed ID: 36244796
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fascin-1 is released from proximal tubular cells in response to calcineurin inhibitors (CNIs) and correlates with isometric vacuolization in kidney transplanted patients.
    Jacobs-Cachá C; Torres IB; López-Hellín J; Cantarell C; Azancot MA; Román A; Moreso F; Serón D; Meseguer A; Sarró E
    Am J Transl Res; 2017; 9(9):4173-4183. PubMed ID: 28979691
    [TBL] [Abstract][Full Text] [Related]  

  • 52. YB-1 increases glomerular, but decreases interstitial fibrosis in CNI-induced nephropathy.
    Gibbert L; Hermert D; Wang J; M Breitkopf D; Alidousty C; Neusser M; Cohen CD; Gröne E; Macheleidt I; Rauen T; Braun GS; Floege J; Ostendorf T; Raffetseder U
    Clin Immunol; 2018 Sep; 194():67-74. PubMed ID: 30018024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calcineurin inhibitor induced nephrotoxicity in steroid resistant nephrotic syndrome.
    Sinha A; Sharma A; Mehta A; Gupta R; Gulati A; Hari P; Dinda AK; Bagga A
    Indian J Nephrol; 2013 Jan; 23(1):41-6. PubMed ID: 23580804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is it time to give up with calcineurin inhibitors in kidney transplantation?
    Salvadori M; Bertoni E
    World J Transplant; 2013 Jun; 3(2):7-25. PubMed ID: 24175203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection and management of nephrotoxicity during drug development.
    Loghman-Adham M; Kiu Weber CI; Ciorciaro C; Mann J; Meier M
    Expert Opin Drug Saf; 2012 Jul; 11(4):581-96. PubMed ID: 22616935
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of Klotho in Chronic Calcineurin Inhibitor Nephropathy.
    Luo K; Lim SW; Quan Y; Cui S; Shin YJ; Ko EJ; Chung BH; Yang CW
    Oxid Med Cell Longev; 2019; 2019():1825018. PubMed ID: 31772699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic progressive calcineurin nephrotoxicity: an overstated concept.
    Matas AJ
    Am J Transplant; 2011 Apr; 11(4):687-92. PubMed ID: 21446973
    [No Abstract]   [Full Text] [Related]  

  • 58. Drug-induced acute kidney injury.
    Schetz M; Dasta J; Goldstein S; Golper T
    Curr Opin Crit Care; 2005 Dec; 11(6):555-65. PubMed ID: 16292059
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AJKD Atlas of Renal Pathology: Calcineurin Inhibitor Nephrotoxicity.
    Lusco MA; Fogo AB; Najafian B; Alpers CE
    Am J Kidney Dis; 2017 May; 69(5):e21-e22. PubMed ID: 28434526
    [No Abstract]   [Full Text] [Related]  

  • 60. Nephrotoxicity: mechanisms, early diagnosis and therapeutic management. 4th International Nephrotoxicity Symposium. Surrey, England, July 1989.
    Ren Fail; 1990; 12(3):133-203. PubMed ID: 1981097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.